Medication
Ended Awarded
- Contract number
- 36C24622N0696
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $11,414
Award facts
- Contract value 100% obligated
- $11,413.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs' Veterans Integrated Service Network 6 awarded a $11,413.72 delivery order to Otsuka America Pharmaceutical Inc. on May 17, 2022, for the supply of medication to be delivered to Potomac, Maryland. This firm fixed-price delivery order, with an ultimate completion date of May 31, 2022, contains no set-aside designation and represents a direct procurement under the company's existing Blanket Purchase Agreement for pharmaceutical products. The award falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), through which the VA efficiently procures specialty medications for veterans across multiple integrated service networks.
Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, maintains significant indefinite delivery vehicles with the VA, including an $83.3 million Blanket Purchase Agreement for Jynarque (tolvaptan), its flagship medication used to treat autosomal dominant polycystic kidney disease and hyponatremia. The company also holds a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products. This delivery order supports the VA's mission to provide specialized pharmaceutical treatments to veterans and demonstrates the company's established capability as a key federal healthcare supplier.
Quick answers
Who was awarded contract 36C24622N0696?
36C24622N0696 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on May 17, 2022.
How much is contract 36C24622N0696 worth?
The government has obligated $11,414 on 36C24622N0696.
Is contract 36C24622N0696 an order under another contract?
Yes. 36C24622N0696 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24622N0696 competed?
The extent of competition for 36C24622N0696 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award